XML 83 R72.htm IDEA: XBRL DOCUMENT v3.20.2
Compensation and Benefit Plans - Additional Information (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
Executive
$ / shares
shares
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Dec. 31, 2019
$ / shares
shares
May 06, 2029
shares
Dec. 31, 2018
$ / shares
Compensation And Benefit Plans Disclosure [Line Items]              
Maximum employer matching contribution percentage     4.00%        
Employer matching contribution percentage     3.00%        
Expenses recognized | $ $ 103 $ 89 $ 474 $ 256      
ESOP related compensation expense including equalization expense | $ 115 184 $ 402 574      
Number of option grants     40,000   8,918    
Total remaining unrecognized compensation cost | $ $ 519   $ 519        
Weighted average period expected to be recognized     87 months        
Weighted-average exercise price for options | $ / shares $ 12.02 [1]   $ 12.02 [1]   $ 12.78 [1]   $ 12.77
Weighted average remaining contractual life     8 years 1 month 6 days        
Weighted average period expected to be recognized     5 years        
Number of shares exercisable [1] 24,788   24,788   24,788    
Stock repurchase program, number of shares repurchase     1,346,679        
2018 Long-Term Incentive Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
Equity incentive plans, maximum number of shares issuable 1,248,469   1,248,469        
Common stock reserved for future issuance 1,248,469   1,248,469        
Conversion of issuable stock options to issuable restricted stock ratio     3.0        
Number of issuable stock options converted into restricted stock units     462,522        
Number of restricted stock units converted from issuable stock options     154,174        
Number of grants     674,645        
Conversion of issuable stock options to issuable restricted stock 60,159   60,159   88,492    
Stock repurchase program, number of shares repurchase     1,436,814        
Stock repurchase program, weighted average price per share | $ / shares     $ 13.62        
2018 Long-Term Incentive Plan | Executive Officers              
Compensation And Benefit Plans Disclosure [Line Items]              
Vesting percentage     20.00%        
2018 Long-Term Incentive Plan | Directors              
Compensation And Benefit Plans Disclosure [Line Items]              
Vesting percentage     20.00%        
Vesting period     10 years        
2020 Long-Term Incentive Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of issuable stock options converted into restricted stock units     45,000        
Number of restricted stock units converted from issuable stock options     15,000        
Stock Options or Stock Appreciation Rights | 2018 Long-Term Incentive Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
Common stock reserved for future issuance 891,764   891,764        
Shares available for future awards 180,476   180,476   265,476    
Restricted Stock Units              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     15,000   29,725    
Compensation expense | $ $ 319 314 $ 956 923      
Total remaining unrecognized compensation cost | $ $ 4,477   $ 4,477        
Weighted average period expected to be recognized     87 months        
Restricted Stock Units | 2018 Long-Term Incentive Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
Common stock reserved for future issuance 356,705   356,705        
Shares available for future awards 0   0     0  
Restricted Stock Units | 2018 Long-Term Incentive Plan | Executive Officers              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     322,254        
Restricted Stock Units | 2018 Long-Term Incentive Plan | Outside Directors              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     148,625        
Restricted Stock Units | 2018 Long-Term Incentive Plan | Non-Executive Officers              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     40,000        
Restricted Stock Units | 2018 Long-Term Incentive Plan | Non-Executive Officers | September 30, 2020              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     15,000        
Restricted Stock Units | 2018 Long-Term Incentive Plan | Directors              
Compensation And Benefit Plans Disclosure [Line Items]              
Stock repurchase program, shares reissued of restricted stock units     90,135        
Incentive Options | 2018 Long-Term Incentive Plan | Executive Officers              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of option grants     119,176        
Incentive Options | 2018 Long-Term Incentive Plan | Non-Executive Officers | September 30, 2020              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of stock grants     40,000        
Non-qualified Options | 2018 Long-Term Incentive Plan | Outside Directors              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of option grants     44,590        
Stock Options              
Compensation And Benefit Plans Disclosure [Line Items]              
Compensation expense | $ $ 33 29 $ 93 $ 77      
Weighted average period expected to be recognized     6 years 6 months 6 years 6 months      
Supplemental Executive Retirement Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
Number of key executive under retirement plan | Executive 1            
Expense recognized | $ $ 15 $ 12 $ 45 $ 45      
Employee Stock Ownership Plan              
Compensation And Benefit Plans Disclosure [Line Items]              
ESOP borrowed amount | $ $ 7,238   $ 7,238        
Number of ESOP shares purchased     723,751        
ESOP shares purchased expressed as percentage of common stock issued in stock offering     3.92%        
Expected period of loan repaid     15 years        
[1] The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at respective periods and the stated exercise price of the underlying options, was $0 and $315 for outstanding options and $0 and $48 for exercisable options at September 30, 2020 and December 31, 2019, respectively.